Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

Jocelyn A. Kramer; D. Curran; M. Piccart; J.C.J.M. Haes de; P.F. Bruning; J.G.M. Klijn; M. Bontenbal; C. Pottelsberghe van; Mogens Grønvold; R. Paridaens

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

Jocelyn A. Kramer, D. Curran, M. Piccart, J.C.J.M. Haes de, P.F. Bruning, J.G.M. Klijn, M. Bontenbal, C. Pottelsberghe van, Mogens Grønvold, R. Paridaens

Section of Health Services Research

38 Citations (Scopus)

Abstract

Cancer, Health-related quality of life

Original language	English
Journal	European Journal of Cancer
Issue number	36
Pages (from-to)	1488-1497
ISSN	0959-8049
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Kramer, J. A., Curran, D., Piccart, M., Haes de, J. C. J. M., Bruning, P. F., Klijn, J. G. M., Bontenbal, M., Pottelsberghe van, C., Grønvold, M., & Paridaens, R. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. European Journal of Cancer, (36), 1488-1497.

Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. / Kramer, Jocelyn A.; Curran, D.; Piccart, M. et al.

In: European Journal of Cancer, No. 36, 2000, p. 1488-1497.

Research output: Contribution to journal › Journal article › Research › peer-review

Kramer, JA, Curran, D, Piccart, M, Haes de, JCJM, Bruning, PF, Klijn, JGM, Bontenbal, M, Pottelsberghe van, C, Grønvold, M & Paridaens, R 2000, 'Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist', European Journal of Cancer, no. 36, pp. 1488-1497.

@article{346cfa4074c811dbbee902004c4f4f50,

title = "Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist",

abstract = "Cancer, Health-related quality of life",

author = "Kramer, {Jocelyn A.} and D. Curran and M. Piccart and {Haes de}, J.C.J.M. and P.F. Bruning and J.G.M. Klijn and M. Bontenbal and {Pottelsberghe van}, C. and Mogens Gr{\o}nvold and R. Paridaens",

year = "2000",

language = "English",

pages = "1488--1497",

journal = "European Journal of Cancer, Supplement",

issn = "0959-8049",

publisher = "Pergamon",

number = "36",

}

TY - JOUR

T1 - Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

AU - Kramer, Jocelyn A.

AU - Curran, D.

AU - Piccart, M.

AU - Haes de, J.C.J.M.

AU - Bruning, P.F.

AU - Klijn, J.G.M.

AU - Bontenbal, M.

AU - Pottelsberghe van, C.

AU - Grønvold, Mogens

AU - Paridaens, R.

PY - 2000

Y1 - 2000

N2 - Cancer, Health-related quality of life

AB - Cancer, Health-related quality of life

M3 - Journal article

SN - 0959-8049

SP - 1488

EP - 1497

JO - European Journal of Cancer, Supplement

JF - European Journal of Cancer, Supplement

IS - 36

ER -